Jan 11, 2021 8:30am EST ProPhase Labs to Present at the NobleCon17 Annual Small & Microcap Investor Conference on Tuesday, January 19, 2021 at 12:45 p.m. Eastern Time
Jan 05, 2021 12:10pm EST ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants
Dec 08, 2020 4:15pm EST ProPhase Labs Expands COVID-19 Testing Capacity with New 25,000 Square Feet Testing Facility in Garden City, New York
Nov 16, 2020 8:30am EST ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2020
Nov 10, 2020 8:30am EST ProPhase Labs to Present at the Virtual Fall Investor Summit on Monday, November 16, 2020 at 2:30 p.m. Eastern Time
Nov 02, 2020 8:30am EST ProPhase Labs Completes Acquisition of CLIA Accredited Lab and Provides Corporate Update
Oct 23, 2020 8:30am EDT ProPhase Labs Announces Definitive Agreement to Acquire CLIA Accredited Lab Certified for COVID-19 and Upper Respiratory Testing
Sep 30, 2020 5:04pm EDT ProPhase Labs Engages Industry Expert to Advise on Possible Acquisition of CLIA Accredited Labs Certified for COVID-19 and Other Testing
Sep 30, 2020 8:30am EDT ProPhase Labs Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
